Reaction
Arterial Disorder reporting signals
As of the last recalculation, Arterial Disorder appears in 1,888 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is NILOTINIB (PRR 27.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nilotinib | 70 | 27.1 | 27.2 |
| Basiliximab | 18 | 17.0 | 17.1 |
| Atazanavir | 17 | 13.2 | 13.2 |
| Prasugrel Hydrochloride | 12 | 13.1 | 13.1 |
| Ranolazine | 12 | 12.8 | 12.8 |
| Bosutinib | 9 | 11.1 | 11.1 |
| Ezetimibe And Simvastatin | 13 | 9.5 | 9.5 |
| Imatinib | 13 | 8.2 | 8.2 |
| Valsartan And Hydrochlorothiazide | 10 | 8.2 | 8.2 |
| Raltegravir | 12 | 8.1 | 8.1 |
| Niacin | 8 | 7.6 | 7.6 |
| Tamsulosin Hydrochloride | 13 | 7.1 | 7.1 |
| Clopidogrel | 119 | 7.0 | 7.0 |
| Human Insulin | 7 | 6.2 | 6.2 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 4 | 5.2 | 5.2 |
| Tiotropium Bromide Inhalation Spray | 5 | 4.9 | 4.9 |
| Ticagrelor | 14 | 4.9 | 4.9 |
| Imatinib Mesylate | 12 | 4.8 | 4.8 |
| Inclisiran | 3 | 4.1 | 4.1 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 4.0 | 4.0 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 3.0 | 3.0 |
| Benralizumab | 5 | 2.8 | 2.8 |
| Evolocumab | 29 | 2.0 | 2.0 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 5 | 1.8 | 1.8 |